BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008; 14(2): 193-199 [PMID: 18186554 DOI: 10.3748/wjg.14.193]
URL: https://www.wjgnet.com/1007-9327/full/v14/i2/193.htm
(0) (0) (12659) (287)
Number Citing Articles
1
Wojciech G. Garbacz, Jeffrey T. J. Huang, Larry G. Higgins, Walter Wahli, Colin N. A. Palmer. PPARαIs Required for PPARδAction in Regulation of Body Weight and Hepatic Steatosis in Mice. PPAR Research 2015; 2015 doi: 10.1155/2015/927057
2
Nishanth E. Sunny, Elizabeth J. Parks, Jeffrey D. Browning, Shawn C. Burgess. Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease. Cell Metabolism 2011; 14(6) doi: 10.1016/j.cmet.2011.11.004
3
Meredith V. Brown, Sarah A. Compton, Michael V. Milburn, Kay A. Lawton, Bentley Cheatham. Metabolomic signatures in lipid‐loaded HepaRGs reveal pathways involved in steatotic progression. Obesity 2013; 21(12) doi: 10.1002/oby.20440
4
Thomas Stuut, Oana Popescu, Angelica Oviedo. N-Glycanase 1 Deficiency Is a Rare Cause of Pediatric Neurodegeneration With Neuronal Inclusions and Liver Steatosis. Cureus 2021;  doi: 10.7759/cureus.19126
5
Vaishaali Natarajan, Christina L. Wilson, Stephen L. Hayward, Srivatsan Kidambi, Guillermo López Lluch. Titanium Dioxide Nanoparticles Trigger Loss of Function and Perturbation of Mitochondrial Dynamics in Primary Hepatocytes. PLOS ONE 2015; 10(8) doi: 10.1371/journal.pone.0134541
6
J. D. Mosinski, M. R. Pagadala, A. Mulya, H. Huang, O. Dan, H. Shimizu, E. Batayyah, R. K. Pai, P. R. Schauer, S. A. Brethauer, J. P. Kirwan. Gastric bypass surgery is protective from high‐fat diet‐induced non‐alcoholic fatty liver disease and hepatic endoplasmic reticulum stress. Acta Physiologica 2016; 217(2) doi: 10.1111/apha.12640
7
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 2019; 20(7) doi: 10.1111/obr.12853
8
Metabolic Syndrome and Cardiovascular Disease. 2012;  doi: 10.1002/9781118480045.ch15
9
Bianca M. Gregorio, Vanessa Souza-Mello, Jorge J. Carvalho, Carlos A. Mandarim-de-Lacerda, Marcia B. Aguila. Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. American Journal of Obstetrics and Gynecology 2010; 203(5) doi: 10.1016/j.ajog.2010.06.042
10
Simone Carotti, Daniele Lettieri-Barbato, Fiorella Piemonte, Sergio Ruggiero, Marco Rosina, Francesca Zalfa, Maria Zingariello, Francesca Arciprete, Francesco Valentini, Maria Francesconi, Jessica D’Amico, Antonio De Vincentis, Andrea Baiocchini, Giuseppe Perrone, Raffaele Antonelli-Incalzi, Sergio Morini, Antonio Picardi, Katia Aquilano, Umberto Vespasiani-Gentilucci. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver. Cell Death & Disease 2021; 12(12) doi: 10.1038/s41419-021-04382-4
11
Huseyin Korkmaz, Gülhan K. Unler, Huseyin S. Gokturk, Wolfgang E. Schmidt, Levent Kebapcilar. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test. European Journal of Gastroenterology & Hepatology 2015; 27(10) doi: 10.1097/MEG.0000000000000407
12
Ying Liu, Yang Hu, Zhao-Liang Shan. Mitochondrial DNA release mediates metabolic-associated steatohepatitis via activation of inflammatory pathways. World Chinese Journal of Digestology 2025; 33(5) doi: 10.11569/wcjd.v33.i5.344
13
Sven Haufe, Stefan Engeli, Petra Budziarek, Wolfgang Utz, Jeanette Schulz-Menger, Mario Hermsdorf, Susanne Wiesner, Christoph Otto, Verena Haas, Armin de Greiff, Friedrich C. Luft, Michael Boschmann, Jens Jordan. Cardiorespiratory Fitness and Insulin Sensitivity in Overweight or Obese Subjects May Be Linked Through Intrahepatic Lipid Content. Diabetes 2010; 59(7) doi: 10.2337/db09-1200
14
Guifen Qiang, Li Zhang, Xiuying Yang, Qi Xuan, Lili Shi, Hengai Zhang, Bainian Chen, Xiaoxiu Li, Mian Zu, Dan Zhou, Jing Guo, Haiguang Yang, Guanhua Du. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes. European Journal of Pharmacology 2012; 685(1-3) doi: 10.1016/j.ejphar.2012.04.028
15
Yuanyuan Hu, Fawen Yin, Zhongyuan Liu, Hongkai Xie, Yunsheng Xu, Dayong Zhou, Beiwei Zhu. Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice. Food & Function 2020; 11(1) doi: 10.1039/C9FO01611B
16
Armando Butanda-Ochoa, Carlos Alberto Ayhllon-Osorio, Rolando Hernández-Muñoz. Toxicology. 2021;  doi: 10.1016/B978-0-12-819092-0.00029-7
17
Francesca Romana Ponziani, Silvia Pecere, Antonio Gasbarrini, Veronica Ojetti. Physiology and pathophysiology of liver lipid metabolism. Expert Review of Gastroenterology & Hepatology 2015; 9(8) doi: 10.1586/17474124.2015.1056156
18
Carine Lindquist, Bodil Bjørndal, Christine Renate Rossmann, Asbjørn Svardal, Seth Hallström, Rolf Kristian Berge, Catherine Mounier. A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis. PLOS ONE 2018; 13(3) doi: 10.1371/journal.pone.0194978
19
David G. Le Couteur, David A. Sinclair, Victoria C. Cogger, Aisling C. McMahon, Alessandra Warren, Arthur V. Everitt, Michel Lebel, Rafael de Cabo. Calorie Restriction, Aging and Longevity. 2010;  doi: 10.1007/978-90-481-8556-6_11
20
Matthew J Eramo, Valerie Lisnyak, Luke E Formosa, Michael T Ryan. The ‘mitochondrial contact site and cristae organising system’ (MICOS) in health and human disease. The Journal of Biochemistry 2020; 167(3) doi: 10.1093/jb/mvz111
21
Ji Cheol Bae, Won Young Lee, Kun Ho Yoon, Joong Yeol Park, Hyun Sik Son, Kyung Ah Han, Kwan Woo Lee, Jeong Taek Woo, Young Cheol Ju, Won Jae Lee, Yoon Young Cho, Moon-Kyu Lee. Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. Diabetes Care 2015; 38(7) doi: 10.2337/dc14-2852
22
Anuradha Krishnan, Tasduq Sheikh Abdullah, Taofic Mounajjed, Stella Hartono, Andrea McConico, Thomas White, Nathan LeBrasseur, Ian Lanza, Sreekumaran Nair, Gregory Gores, Michael Charlton. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(6) doi: 10.1152/ajpgi.00213.2016
23
Ling-Yu Zhang, Hao-Hao Shi, Cheng-Cheng Wang, Yu-Ming Wang, Zi-Hao Wei, Chang-Hu Xue, Xiang-Zhao Mao, Tian-Tian Zhang. Targeted Lipidomics Reveal the Effects of Different Phospholipids on the Phospholipid Profiles of Hepatic Mitochondria and Endoplasmic Reticulum in High-Fat/High-Fructose-Diet-Induced Nonalcoholic Fatty Liver Disease Mice. Journal of Agricultural and Food Chemistry 2022; 70(11) doi: 10.1021/acs.jafc.1c07538
24
Kang-Le Lu, Wei-Na Xu, Wen-Bin Liu, Li-Na Wang, Chun-Nuan Zhang, Xiang-Fei Li. Association of Mitochondrial Dysfunction with Oxidative Stress and Immune Suppression in Blunt Snout Bream Megalobrama amblycephala Fed a High-Fat Diet. Journal of Aquatic Animal Health 2014; 26(2) doi: 10.1080/08997659.2014.893460
25
Rodrigo Urbina-Varela, Nataly Castillo, Luis A. Videla, Andrea del Campo. Impact of Mitophagy and Mitochondrial Unfolded Protein Response as New Adaptive Mechanisms Underlying Old Pathologies: Sarcopenia and Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(20) doi: 10.3390/ijms21207704
26
Kyung Eun Kim, Youngae Jung, Soonki Min, Miso Nam, Rok Won Heo, Byeong Tak Jeon, Dae Hyun Song, Chin-ok Yi, Eun Ae Jeong, Hwajin Kim, Jeonghyun Kim, Seon-Yong Jeong, Woori Kwak, Do Hyun Ryu, Tamas L. Horvath, Gu Seob Roh, Geum-Sook Hwang. Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. Scientific Reports 2016; 6(1) doi: 10.1038/srep30111
27
Rebecca L. Jensen, Robyn T. Kiy, Faten F. Bin Dayel, Amy E. Chadwick. Mitochondrial Intoxication. 2023;  doi: 10.1016/B978-0-323-88462-4.00026-2
28
D.A.R.K. Dayaratne. Impact of ecology on development of NIDDM. Medical Hypotheses 2010; 74(6) doi: 10.1016/j.mehy.2009.12.017
29
Alessandra Ferramosca, Annalea Conte, Vincenzo Zara. Krill Oil Ameliorates Mitochondrial Dysfunctions in Rats Treated with High-Fat Diet. BioMed Research International 2015; 2015 doi: 10.1155/2015/645984
30
Alexandra Rankovic, Anna K Shoveller, Marica Bakovic, Gordon Kirby, Adronie Verbrugghe. Serum metabolomics reveals one-carbon metabolism differences between lean and obese cats not affected by L-carnitine or choline supplementation. Journal of Animal Science 2025; 103 doi: 10.1093/jas/skaf298
31
Cíntia dos Santos Costa, Thais Ortiz Hammes, Francieli Rohden, Rogério Margis, Josiane Woutheres Bortolotto, Alexandre Vontobel Padoin, Cláudio Cora Mottin, Regina Maria Guaragna. SIRT1 Transcription Is Decreased in Visceral Adipose Tissue of Morbidly Obese Patients with Severe Hepatic Steatosis. Obesity Surgery 2010; 20(5) doi: 10.1007/s11695-009-0052-z
32
Kenneth Cusi. Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications. Gastroenterology 2012; 142(4) doi: 10.1053/j.gastro.2012.02.003
33
Tzung-Hsun Tsai, Chun-Hsien Yu, Yu-Ping Chang, Yu-Ting Lin, Ching-Jang Huang, Yueh-Hsiung Kuo, Po-Jung Tsai. Protective Effect of Caffeic Acid Derivatives on tert-Butyl Hydroperoxide-Induced Oxidative Hepato-Toxicity and Mitochondrial Dysfunction in HepG2 Cells. Molecules 2017; 22(5) doi: 10.3390/molecules22050702
34
Marica Meroni, Miriam Longo, Erika Paolini, Giada Tria, Michela Ripolone, Laura Napoli, Maurizio Moggio, Anna Ludovica Fracanzani, Paola Dongiovanni. Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.967899
35
Shobha H. Ganji, Moti L. Kashyap, Vaijinath S. Kamanna. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. Metabolism 2015; 64(9) doi: 10.1016/j.metabol.2015.05.002
36
M. Kahle, A. Schäfer, A. Seelig, J. Schultheiß, M. Wu, M. Aichler, J. Leonhardt, B. Rathkolb, J. Rozman, H. Sarioglu, S.M. Hauck, M. Ueffing, E. Wolf, G. Kastenmueller, J. Adamski, A. Walch, M. Hrabé de Angelis, S. Neschen. High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice. Molecular Metabolism 2015; 4(1) doi: 10.1016/j.molmet.2014.11.004
37
Richard C. Feldstein, Robert E. Tepper, Seymour Katz. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 2010;  doi: 10.1016/B978-1-4160-6231-8.10017-0
38
Stéphanie A. Bayol, Bigboy H. Simbi, Robert C. Fowkes, Neil C. Stickland. A Maternal “Junk Food” Diet in Pregnancy and Lactation Promotes Nonalcoholic Fatty Liver Disease in Rat Offspring. Endocrinology 2010; 151(4) doi: 10.1210/en.2009-1192
39
Raghu Ramanathan, Ahmad Hassan Ali, Jamal A. Ibdah. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137280
40
Madeline Rose Keleher, Rabab Zaidi, Shyam Shah, M. Elsa Oakley, Cassondra Pavlatos, Samir El Idrissi, Xiaoyun Xing, Daofeng Li, Ting Wang, James M. Cheverud, Cheryl S. Rosenfeld. Maternal high-fat diet associated with altered gene expression, DNA methylation, and obesity risk in mouse offspring. PLOS ONE 2018; 13(2) doi: 10.1371/journal.pone.0192606
41
Mohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Joo Shun Tan, Mohamad Norisham Mohamad Rosdi. Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes. European Journal of Pharmacology 2017; 799 doi: 10.1016/j.ejphar.2017.01.043
42
Mercedes García-Roche, Alberto Casal, Diego A. Mattiauda, Mateo Ceriani, Alejandra Jasinsky, Mauricio Mastrogiovanni, Andrés Trostchansky, Mariana Carriquiry, Adriana Cassina, Celia Quijano, Juan J Loor. Impaired hepatic mitochondrial function during early lactation in dairy cows: Association with protein lysine acetylation. PLOS ONE 2019; 14(3) doi: 10.1371/journal.pone.0213780
43
Francesco Pollicino, Nicola Veronese, Ligia J. Dominguez, Mario Barbagallo. Mediterranean diet and mitochondria: New findings. Experimental Gerontology 2023; 176 doi: 10.1016/j.exger.2023.112165
44
Hyun-Woo Joo, Yi-Sun Song, In-Hwa Park, Guang-Yin Shen, Jin-Hee Seong, Na-Kyoung Shin, A-Hyeon Lee, Hyuck Kim, Kyung-Soo Kim. Granulocyte Colony Stimulating Factor Ameliorates Hepatic Steatosis Associated with Improvement of Autophagy in Diabetic Rats. Canadian Journal of Gastroenterology and Hepatology 2020; 2020 doi: 10.1155/2020/2156829
45
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, Marica Noviello, Leonilde Bonfrate, David Q.-H. Wang, Piero Portincasa. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?. International Journal of Molecular Sciences 2021; 22(10) doi: 10.3390/ijms22105375
46
Aigli-Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, Grigorios Papadopoulos, Rallia-Iliana Velliou, Antonios Chatzigeorgiou. Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. Current Obesity Reports 2022; 11(3) doi: 10.1007/s13679-022-00473-1
47
Young‐Je Kim, Myung‐Sook Choi, Je Tae Woo, Mi Ji Jeong, Sang Ryong Kim, Un Ju Jung. Long‐term dietary supplementation with low‐dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet‐induced obesity. Molecular Nutrition & Food Research 2017; 61(8) doi: 10.1002/mnfr.201600889
48
Soo-Hyun Lee, Moon-Jong Kim, Young-Sang Kim, Hyejin Chun, Bo Youn Won, Joo-Ho Lee, Kunhee Han, Kyu-Sung Rim, Kyung-Chae Park. Low hair copper concentration is related to a high risk of nonalcoholic fatty liver disease in adults. Journal of Trace Elements in Medicine and Biology 2018; 50 doi: 10.1016/j.jtemb.2018.06.001
49
Sophie C. Cazanave, Arun J. Sanyal. Hepatic De Novo Lipogenesis and Regulation of Metabolism. 2016;  doi: 10.1007/978-3-319-25065-6_5
50
Eva Gijbels, Vânia Vilas-Boas, Neel Deferm, Lindsey Devisscher, Hartmut Jaeschke, Pieter Annaert, Mathieu Vinken. Mechanisms and in vitro models of drug-induced cholestasis. Archives of Toxicology 2019; 93(5) doi: 10.1007/s00204-019-02437-2
51
Milena Vesković, Milica Labudović-Borović, Dušan Mladenović, Jelena Jadžić, Bojan Jorgačević, Dušan Vukićević, Danijela Vučević, Tatjana Radosavljević. Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine–Choline-Deficient Diet-Induced NAFLD. Microscopy and Microanalysis 2020; 26(5) doi: 10.1017/S1431927620024265
52
Frode Norheim, Simon T. Hui, Emre Kulahcioglu, Margarete Mehrabian, Rita M. Cantor, Calvin Pan, Brian W. Parks, Aldons J. Lusis. Genetic and hormonal control of hepatic steatosis in female and male mice. Journal of Lipid Research 2017; 58(1) doi: 10.1194/jlr.M071522
53
Jacob A. Goldsmith, Areej N. Ennasr, Gary J. Farkas, David R. Gater, Ashraf S. Gorgey. Role of exercise on visceral adiposity after spinal cord injury: a cardiometabolic risk factor. European Journal of Applied Physiology 2021; 121(8) doi: 10.1007/s00421-021-04688-3
54
Katsutoshi Tokushige, Etsuko Hashimoto, Haruka Noto, Satoru Yatsuji, Maki Tobari, Nobuyuki Torii, Makiko Taniai, Keiko Shiratori, Hiroshi Murayama. Clinical significance of serum ornithine carbamoyltransferase in patients with non‐alcoholic steatohepatitis. Hepatology Research 2009; 39(9) doi: 10.1111/j.1872-034X.2009.00530.x
55
Chiara Valtolina, Robert P. Favier. Feline Hepatic Lipidosis. Veterinary Clinics of North America: Small Animal Practice 2017; 47(3) doi: 10.1016/j.cvsm.2016.11.014
56
Jia-Hung Ye, Jung Chao, Ming-Ling Chang, Wen-Huang Peng, Hao-Yuan Cheng, Jiunn-Wang Liao, Li-Heng Pao. Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. Scientific Reports 2016; 6(1) doi: 10.1038/srep33102
57
Roberta M. Machado, José T. Stefano, Claudia P.M.S. Oliveira, Evandro S. Mello, Fabiana D. Ferreira, Valeria S. Nunes, Vicência M.R. de Lima, Eder C.R. Quintão, Sergio Catanozi, Edna R. Nakandakare, Ana Maria P. Lottenberg. Intake of trans Fatty Acids Causes Nonalcoholic Steatohepatitis and Reduces Adipose Tissue Fat Content. The Journal of Nutrition 2010; 140(6) doi: 10.3945/jn.109.117937
58
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
59
Clint M. Upchurch, Scott Yeudall, Caitlin M. Pavelec, Dennis Merk, Jan Greulich, Mohan Manjegowda, Shyam S. Raghavan, Irina M. Bochkis, Michael M. Scott, Edward Perez-Reyes, Norbert Leitinger. Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis. Science Advances 2022; 8(28) doi: 10.1126/sciadv.abn0050
60
Shuang Gao, Yuanyuan Zhang, Kaini Liang, Ran Bi, Yanan Du, Marta Baiocchi. Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes. Stem Cells International 2022; 2022 doi: 10.1155/2022/8637493
61
Rodrigo Neto-Ferreira, Vinícius Novaes Rocha, Vanessa Souza-Mello, Carlos Alberto Mandarim-de-Lacerda, Jorge José de Carvalho. Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice. Diabetology & Metabolic Syndrome 2013; 5(1) doi: 10.1186/1758-5996-5-32
62
Ying-Chun Wang, Wei-Zong Kong, Qing-Mei Jin, Juan Chen, Lei Dong. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World Journal of Gastroenterology 2015; 21(35): 10104-10112 doi: 10.3748/wjg.v21.i35.10104
63
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
64
Metabolic Syndrome and Cardiovascular Disease. 2012;  doi: 10.1002/9781118480045.ch13
65
Jonathan M. Hazlehurst, Conor Woods, Thomas Marjot, Jeremy F. Cobbold, Jeremy W. Tomlinson. Non-alcoholic fatty liver disease and diabetes. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2016.01.001
66
V. Dimitrijevic-Sreckovic, H. Petrovic, D. Dobrosavljevic, E. Colak, N. Ivanovic, D. Gostiljac, S. Ilic, D. Nikolic, J. Gacic, I. Soldatovic. siMS score- method for quantification of metabolic syndrome, confirms co-founding factors of metabolic syndrome. Frontiers in Genetics 2023; 13 doi: 10.3389/fgene.2022.1041383
67
Xihui Xu, Rozhin Penjweini, Lóránt Székvölgyi, Zsolt Karányi, Anne-Marie Heckel, Devikala Gurusamy, Dóra Varga, Shutong Yang, Alexandra L. Brown, Wenqi Cui, Jinsung Park, Dénes Nagy, Maren C. Podszun, Sarah Yang, Komudi Singh, Stephen P. Ashcroft, Jeonghan Kim, Myung K. Kim, Ivan Tarassov, Jun Zhu, Andrew Philp, Yaron Rotman, Jay R. Knutson, Nina Entelis, Jay H. Chung. Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNA Thr production . Proceedings of the National Academy of Sciences 2025; 122(1) doi: 10.1073/pnas.2411298122
68
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li, Lin Wang. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020; 330 doi: 10.1016/j.cbi.2020.109199
69
Patrycja Puchalska, Peter A. Crawford. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metabolism 2017; 25(2) doi: 10.1016/j.cmet.2016.12.022
70
Jishuang San, Jianmin Hu, Huiping Pang, Wenjun Zuo, Na Su, Zimeng Guo, Gaofeng Wu, Jiancheng Yang. Taurine Protects against the Fatty Liver Hemorrhagic Syndrome in Laying Hens through the Regulation of Mitochondrial Homeostasis. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210360
71
Lingjuan Piao, Jiyeon Choi, Guideock Kwon, Hunjoo Ha. Endogenous catalase delays high-fat diet-induced liver injury in mice. The Korean Journal of Physiology & Pharmacology 2017; 21(3) doi: 10.4196/kjpp.2017.21.3.317
72
Minglan Li, Clare M. Reynolds, Stephanie A. Segovia, Clint Gray, Mark H. Vickers. Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life. BioMed Research International 2015; 2015 doi: 10.1155/2015/437107
73
Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett, Nina Isoherranen. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver. Molecular Pharmacology 2016; 89(5) doi: 10.1124/mol.116.103697
74
Meng-Xiao Feng, Hua Zou, Yuan-Qiang Lu. Severe liver injury and clinical characteristics of occupational exposure to 2-amino-5-chloro-N,3-dimethylbenzamide: A case series. Hepatobiliary & Pancreatic Diseases International 2024; 23(2) doi: 10.1016/j.hbpd.2023.10.008
75
Avraham Mayevsky. Mitochondrial Function In Vivo Evaluated by NADH Fluorescence. 2015;  doi: 10.1007/978-3-319-16682-7_1
76
Kayleigh M. Beaudry, Michaela C. Devries. Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism. Applied Physiology, Nutrition, and Metabolism 2019; 44(8) doi: 10.1139/apnm-2018-0635
77
Dalia M. Miller, Kiana F. McCauley, Kimberly J. Dunham‐Snary. Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances. Endocrinology, Diabetes & Metabolism 2025; 8(6) doi: 10.1002/edm2.70132
78
George S Zacharia, Muhammad H Ashraf, Franklin Sosa, Anu Jacob, Harish Patel. Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends. World Journal of Gastrointestinal Pharmacology and Therapeutics 2025; 16(4): 110827 doi: 10.4292/wjgpt.v16.i4.110827
79
Federico Salamone, Fabio Galvano, Antonella Marino, Claudia Paternostro, Daniele Tibullo, Fabio Bucchieri, Andrea Mangiameli, Maurizio Parola, Elisabetta Bugianesi, Giovanni Li Volti. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Digestive and Liver Disease 2012; 44(4) doi: 10.1016/j.dld.2011.11.010
80
Macarena Ortiz, Sandra A. Soto-Alarcón, Paula Orellana, Alejandra Espinosa, Cristian Campos, Sandra López-Arana, Miguel A. Rincón, Paola Illesca, Rodrigo Valenzuela, Luis A. Videla. Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. Digestive and Liver Disease 2020; 52(8) doi: 10.1016/j.dld.2020.04.019
81
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi. Oxidative Stress in Non-Alcoholic Fatty Liver Disease. Livers 2022; 2(1) doi: 10.3390/livers2010003
82
Melissa A. Linden, Grace M. Meers, Meghan L. Ruebel, Nathan T. Jenkins, Frank W. Booth, M. Harold Laughlin, Jamal A. Ibdah, John P. Thyfault, R. Scott Rector. Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2013; 304(9) doi: 10.1152/ajpregu.00537.2012
83
Hongwei Lin, Dazhi Chen, Qianjing Du, Tongtong Pan, Hanxiao Tu, Yuedong Xu, Teng Teng, Jingjing Tu, Ji Li, Zhuo Lin, Xiaodong Wang, Lanman Xu, Yong-Ping Chen. Dietary Copper Plays an Important Role in Maintaining Intestinal Barrier Integrity During Alcohol-Induced Liver Disease Through Regulation of the Intestinal HIF-1α Signaling Pathway and Oxidative Stress. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00369
84
Arun Baidya, Indrani Ghosh, Shuvam Sar, Tanmoy Banerjee, Ankit Kumar, Saptapadi Saha, Rituparna Chaki, Amit Kumar Halder, Nilanjan Ghosh. Nanobiomaterials and Nanomedicines for Metabolic Disorders. 2026;  doi: 10.1016/B978-0-443-28942-2.00007-7
85
Temidayo Ogunmoyole, Iretiogo Dada, Oluwatosin Adebukola Adebamigbe. RETRACTED ARTICLE: Ameliorative potentials of Persea americana leaf extract on toxicants - induced oxidative assault in multiple organs of wistar albino rat. Clinical Phytoscience 2021; 7(1) doi: 10.1186/s40816-020-00237-1
86
Kohei Ariyoshi, Kazuhiro Nishiyama, Yuri Kato, Xinya Mi, Tomoya Ito, Yasu-Taka Azuma, Akiyuki Nishimura, Motohiro Nishida. Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105446
87
Sophie Wolfgramm, Sara Alehashemi, Martin Wendlandt, Franziska G. Thiel, Adriana A. de Jesus, Jonas J. Papendorf, Hannes Wolfgramm, Flavia Llorente Alvarez, Emely Borngräber, Kat Uss, Farzana Bhuyan, Anvitha Metpally, Leif Steil, Christian Hentschker, Simone Venz, Ruba Al Abdulla, Léa Poirier, Christopher Friend, Fabiola Castello Casta, Iren Horkayne-Szakaly, Shoghik Akoghlanian, Peter J. Mustillo, Roshini S. Abraham, Paul Bastard, Thais C.L. Moura, Mayra B. Dorna, Katia T. Kozu, Jesper Kers, Y. K. Onno Teng, Robbert G.M. Bredius, Karin Palmblad, AnnaCarin Horne, Petter Brodin, Pilar Blanco-Lobo, José Bernabeu-Wittel, Laura Fernandez-Silveira, Olaf Neth, Anne Pagnier, Guilaine Boursier, Maud Tusseau, Thomas W.J. Huizinga, Benjamin Fournier, Bénédicte Neven, Uwe Völker, Gijs W.E. Santen, Jason M. Brenchley, Katherine R. Calvo, David Kleiner, Frédéric Ebstein, Elke Krüger, Raphaela Goldbach-Mansky. A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis. Annals of the Rheumatic Diseases 2026; 85(4) doi: 10.1016/j.ard.2025.10.021
88
Yi Zhang, Jing Zhao, Shu-Feng Zhou, Zhi-Ling Yu, Xiao-Yan Wang, Pei-Li Zhu, Zhu-Sheng Chu, Si-Yuan Pan, Ming Xie, Kam-Ming Ko. Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0406-9
89
Christopher Auger, Thibacg Sivayoganathan, Abdikarim Abdullahi, Alexandra Parousis, Marc G. Jeschke. Hepatic mitochondrial bioenergetics in aged C57BL/6 mice exhibit delayed recovery from severe burn injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(11) doi: 10.1016/j.bbadis.2017.07.006
90
Xinnan Gu, Yuxuan Luo, Jinyu Zhang, Hao Ouyang, Zijing Kong, Tao Wang, Zhenlin Huang, Lili Ji. The therapeutic role of natural compounds mediated through Nrf2 in metabolic dysfunction-associated steatotic liver disease. Biochemical Pharmacology 2026; 250 doi: 10.1016/j.bcp.2026.117989
91
Elmar Aigner, Günter Weiss, Christian Datz. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World Journal of Hepatology 2015; 7(2): 177-188 doi: 10.4254/wjh.v7.i2.177
92
Helena Cortez-Pinto, Mariana V. Machado. Uncoupling proteins and non-alcoholic fatty liver disease. Journal of Hepatology 2009; 50(5) doi: 10.1016/j.jhep.2009.02.019
93
T. GARNOL, R. ENDLICHER, O. KUČERA, Z. DRAHOTA, Z. ČERVINKOVÁ. Impairment of Mitochondrial Function of Rat Hepatocytes by High Fat Diet and Oxidative Stress. Physiological Research 2014;  doi: 10.33549/physiolres.932645
94
Xintong Tan, Tong Zhao, Zihan Wang, Jia Wang, Yijie Wang, Zhigang Liu, Xuebo Liu. Acrylamide Defects the Expression Pattern of the Circadian Clock and Mitochondrial Dynamics in C57BL/6J Mice Liver and HepG2 Cells. Journal of Agricultural and Food Chemistry 2018; 66(39) doi: 10.1021/acs.jafc.8b02473
95
Dana Lin, Eileen A. Lacey, Bryan H. Bach, Ke Bi, Christopher J. Conroy, Anton Suvorov, Rauri C. K. Bowie. Gut microbial diversity across a contact zone for California voles: Implications for lineage divergence of hosts and mitonuclear mismatch in the assembly of the mammalian gut microbiome. Molecular Ecology 2020; 29(10) doi: 10.1111/mec.15443
96
Yongzhong Wei, Suzanne E. Clark, John P. Thyfault, Grace M.E. Uptergrove, Wenhan Li, Adam T. Whaley-Connell, Carlos M. Ferrario, James R. Sowers, Jamal A. Ibdah. Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats. The American Journal of Pathology 2009; 174(4) doi: 10.2353/ajpath.2009.080697
97
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
98
Connor A Mahler, Deena B Snoke, Rachel M Cole, Austin Angelotti, Genevieve C Sparagna, Kedryn K Baskin, Ai Ni, Martha A Belury. Consuming a Linoleate-Rich Diet Increases Concentrations of Tetralinoleoyl Cardiolipin in Mouse Liver and Alters Hepatic Mitochondrial Respiration. The Journal of Nutrition 2024; 154(3) doi: 10.1016/j.tjnut.2023.12.037
99
Fei Ren, Qianping Chen, Chen Meng, Haiming Chen, Yongjie Zhou, Hao Zhang, Weijun Chen. Serum metabonomics revealed the mechanism of Ganoderma amboinense polysaccharides in preventing non-alcoholic fatty liver disease (NAFLD) induced by high-fat diet. Journal of Functional Foods 2021; 82 doi: 10.1016/j.jff.2021.104496
100
Sharareh Kamfar, Seyed Moayed Alavian, Kambiz Hasrak, Massoud Houshmand, Bahram Seifi Zarei, Alireza Khalaj, Forough Homaunpur, Massoud Saidijam. Analysis of Mitochondrial 4977-bp Deletion and D-Loop Variation in Iranian Non-Alcoholic Fatty Liver Disease Patients. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84553
101
Yingqing Chen, Indira Pandiri, Yeonsoo Joe, Hyo Jeong Kim, Seul-Ki Kim, Jeongmin Park, Jinhyun Ryu, Gyeong Jae Cho, Jeong Woo Park, Stefan W. Ryter, Hun Taeg Chung, Borna Relja. Synergistic Effects of Cilostazol and Probucol on ER Stress‐Induced Hepatic Steatosis via Heme Oxygenase‐1‐Dependent Activation of Mitochondrial Biogenesis. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/3949813
102
Rui Zhang, Kyoung Ah Kang, Mei Jing Piao, Weon Young Chang, Young Hee Maeng, Sungwook Chae, In Kyung Lee, Bum Joon Kim, Jin Won Hyun. Butin reduces oxidative stress-induced mitochondrial dysfunction via scavenging of reactive oxygen species. Food and Chemical Toxicology 2010; 48(3) doi: 10.1016/j.fct.2010.01.001
103
Cristina Galarregui, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Víctor de la O, Miguel Ruiz-Canela, Helen Hermana M. Hermsdorff, Josefina Bressan, Josep A. Tur, J. Alfredo Martínez, M. Angeles Zulet, Itziar Abete. Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study. European Journal of Nutrition 2021; 60(4) doi: 10.1007/s00394-020-02370-6
104
Anna Maria Birkl-Toeglhofer, Christoph Birkl, Ida Cirila Llenos, Serge Weis, Johannes Haybaeck. Hepatic gene expression explains primary drug toxicity in bipolar disorder. Translational Psychiatry 2019; 9(1) doi: 10.1038/s41398-019-0666-4
105
Raghu Ramanathan, Jamal A. Ibdah. Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23073595
106
Ming Tong, Lisa Longato, Suzanne M de la Monte. Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration. BMC Endocrine Disorders 2010; 10(1) doi: 10.1186/1472-6823-10-4
107
Madlen Matz-Soja, Christiane Rennert, Kristin Schönefeld, Susanne Aleithe, Jan Boettger, Wolfgang Schmidt-Heck, Thomas S Weiss, Amalya Hovhannisyan, Sebastian Zellmer, Nora Klöting, Angela Schulz, Jürgen Kratzsch, Reinhardt Guthke, Rolf Gebhardt. Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis. eLife 2016; 5 doi: 10.7554/eLife.13308
108
Sharareh Kamfar, Bardia Danaei, Samane Rahimi, Vahide Zeinali. Novel blood and tissue-based mitochondrial D-loop mutations detected in an Iranian NAFLD patient cohort. Mitochondrion 2024; 77 doi: 10.1016/j.mito.2024.101888
109
Gabriela S. F. Castro, João F. R. Cardoso, Helio Vannucchi, Sérgio Zucoloto, Alceu Afonso Jordão. Fructose and NAFLD: metabolic implications and models of induction in rats. Acta Cirurgica Brasileira 2011; 26(suppl 2) doi: 10.1590/S0102-86502011000800009
110
Jignesh D. Pandya, Matthew Valdez, Joyce E. Royland, Robert C. MacPhail, Patrick G. Sullivan, Prasada Rao S. Kodavanti. Age- and Organ-Specific Differences in Mitochondrial Bioenergetics in Brown Norway Rats. Journal of Aging Research 2020; 2020 doi: 10.1155/2020/7232614
111
Adronie Verbrugghe, Alexandra Rankovic, Shafeeq Armstrong, Amanda Santarossa, Gordon M. Kirby, Marica Bakovic. Serum Lipid, Amino Acid and Acylcarnitine Profiles of Obese Cats Supplemented with Dietary Choline and Fed to Maintenance Energy Requirements. Animals 2021; 11(8) doi: 10.3390/ani11082196
112
Yaping Shao, Bin Zhu, Ruiyin Zheng, Xinjie Zhao, Peiyuan Yin, Xin Lu, Binghua Jiao, Guowang Xu, Zhenzhen Yao. Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker Discovery. Journal of Proteome Research 2015; 14(2) doi: 10.1021/pr500973d
113
Jun‐Ho Cho, Goo‐Young Kim, Brian C. Mansfield, Janice Y. Chou. Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia. Journal of Inherited Metabolic Disease 2018; 41(6) doi: 10.1007/s10545-018-0192-1
114
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018;  doi: 10.1016/B978-0-12-812504-5.00006-4
115
Amedeo Lonardo, Ralf Weiskirchen. Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity. Metabolism and Target Organ Damage 2024;  doi: 10.20517/mtod.2024.47
116
Yukihiro Shimizu. Liver in systemic disease. World Journal of Gastroenterology 2008; 14(26): 4111-4119 doi: 10.3748/wjg.14.4111
117
Huai Zhang, Kenneth I. Zheng, Pei-Wu Zhu, Sui-Dan Chen, Gang Li, Hong-Lei Ma, Liang-Jie Tang, Ou-Yang Huang, Christopher D. Byrne, Giovanni Targher, Xiao-Dong Wang, Ming-Hua Zheng. Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case–control study. European Journal of Gastroenterology & Hepatology 2022; 34(8) doi: 10.1097/MEG.0000000000002392
118
D. Voieikova, L. Stepanova, T. Beregova, L. Ostapchenko, M. Kondro. Phospholipid composition of the inner mitochondrial membrane of rat hepatocytes upon development of different types of steatohepatosis. Bulletin of Taras Shevchenko National University of Kyiv. Series: Problems of Physiological Functions Regulation 2016; 20(1) doi: 10.17721/2616_6410.2016.20.30-33
119
Robert Hirten, Henry C. Bodenheimer, Douglas F. Meyer, David Bernstein. Principles of Diabetes Mellitus. 2017;  doi: 10.1007/978-3-319-20797-1_35-2
120
Agostino Di Ciaula, Giuseppe Calamita, Harshitha Shanmugam, Mohamad Khalil, Leonilde Bonfrate, David Q.-H. Wang, Gyorgy Baffy, Piero Portincasa. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. International Journal of Molecular Sciences 2021; 22(14) doi: 10.3390/ijms22147702
121
P. Wainwright, E. Scorletti, C. D. Byrne. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. Current Diabetes Reports 2017; 17(4) doi: 10.1007/s11892-017-0851-x
122
Ángeles Ruiz‐Extremera, Ángel Carazo, Ángela Salmerón, Josefa León, Jorge Casado, Alejandro Goicoechea, José Manuel Fernandez, Maximiliano Garofano, Esther Ocete, Ana Belén Martín, Esther Pavón, Javier Salmerón. Factors Associated With Hepatic Steatosis in Obese Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition 2011; 53(2) doi: 10.1097/MPG.0b013e3182185ac4
123
Ditte Marie Kirkegaard-Klitbo, Andreas Fuchs, Stefan Stender, Per Ejlstrup Sigvardsen, Jørgen Tobias Kühl, Klaus Fuglsang Kofoed, Lars Køber, Børge G Nordestgaard, Flemming Bendtsen, Amanda Mocroft, Jens Lundgren, Susanne Dam Nielsen, Thomas Benfield. Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study. The Journal of Infectious Diseases 2020; 222(8) doi: 10.1093/infdis/jiaa246
124
Alistair V.W. Nunn, Geoffrey W. Guy, Jimmy D. Bell. Endocannabinoids, FOXO and the metabolic syndrome: Redox, function and tipping point – The view from two systems. Immunobiology 2010; 215(8) doi: 10.1016/j.imbio.2009.03.005
125
Robert Hirten, Henry C. Bodenheimer, David Bernstein. Principles of Diabetes Mellitus. 2017;  doi: 10.1007/978-3-319-18741-9_35
126
Chong Yin, Siqi Liu, Rui Shao, Pong C. Yuen. Medical Image Computing and Computer Assisted Intervention – MICCAI 2021. Lecture Notes in Computer Science 2021; 12905 doi: 10.1007/978-3-030-87240-3_15
127
Hendrian Sukardi, Xiaoyan Zhang, Eei Yin Lui, Choong Yong Ung, Sinnakaruppan Mathavan, Zhiyuan Gong, Siew Hong Lam. Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: Histological, gene set enrichment and expression analyses. Biochimica et Biophysica Acta (BBA) - General Subjects 2012; 1820(1) doi: 10.1016/j.bbagen.2011.10.009
128
Avraham Mayevsky, Efrat Barbiro-Michaely. Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: I. Basic methodology and animal studies. Journal of Clinical Monitoring and Computing 2013; 27(1) doi: 10.1007/s10877-012-9414-5
129
Bingya Ma, Yihang Fan, Wenjun Fan. Shift work and metabolic dysfunction-associated steatotic liver disease: a systematic review of observational studies. International Archives of Occupational and Environmental Health 2025; 98(9-10) doi: 10.1007/s00420-025-02171-6
130
Rabab S. Hamad, Sura Akram Mohammed, Waseem Ali Hasan, Norhan Ahmed AbuoHashish, Sherin Refat El Afify, Mohamed A.M. Ali, Alaa Eldin Ahmed Mohamed, Attalla F. El-kott, Mohammed A. AlShehri, Kareem Morsy, Alshaimaa A. Farrag, Karem Mohamed Salem, Nesreen Elsayed Morsy, Rasha Elmowafy, Ahmed Abdel-monem Elmetwally, Walid Mostafa Sayed Ahmed, Lubna Jamil, Ahmed Shata, Anis Ahmad Chaudhary, Hanan Eissa, Sameh Saber. Interrupting a mitochondrial DNA–driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitis. Tissue and Cell 2026; 103 doi: 10.1016/j.tice.2026.103733
131
M Banasch, M Ellrichmann, A Tannapfel, WE Schmidt, O Goetze. The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. European Journal of Medical Research 2011; 16(6) doi: 10.1186/2047-783X-16-6-258
132
Zhiyong Cheng, Morris F. White. Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models. Antioxidants & Redox Signaling 2011; 14(4) doi: 10.1089/ars.2010.3370
133
Xi Xu, Xiao-Peng Zhu, Jin-Yun Bai, Pu Xia, Yu Li, Yan Lu, Xiao-Ying Li, Xin Gao. Berberine alleviates nonalcoholic fatty liver induced by a high‐fat diet in mice by activating SIRT3. The FASEB Journal 2019; 33(6) doi: 10.1096/fj.201802316R
134
Parvin Farzanegi, Amir Dana, Zeynab Ebrahimpoor, Mahdieh Asadi, Mohammad Ali Azarbayjani. Mechanisms of beneficial effects of exercise training on non‐alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European Journal of Sport Science 2019; 19(7) doi: 10.1080/17461391.2019.1571114
135
Muhanad Elhafiz, Guolin Zhao, Mohammed Ismail, Dengqiu Xu, Debanjan Das, Sisi Fan, Nong Cheng, Bashir A. Yousef, Zhenzhou Jiang, Luyong Zhang. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(6) doi: 10.1016/j.bbalip.2020.158657
136
Jinhai Luo, Jincan Luo, Yingzi Wu, Nannan Wang, Yu Fu, Bincheng Han, Yongxin Ren, Baojun Xu. Soyasaponin Ba Alleviates Lipid Accumulation via Mitochondrial Remodeling: Multiomics Insights. Journal of Agricultural and Food Chemistry 2025; 73(33) doi: 10.1021/acs.jafc.5c06945
137
Qiuyi Li, Yuan Huang. Mitochondrial targeted strategies and their application for cancer and other diseases treatment. Journal of Pharmaceutical Investigation 2020; 50(3) doi: 10.1007/s40005-020-00481-0
138
Mercedes García-Roche, Daniel Talmón, Guillermo Cañibe, Ana Laura Astessiano, Alejandro Mendoza, Adriana Cassina, Celia Quijano, Mariana Carriquiry, Arda Yildirim. Hepatic metabolism of grazing cows of two Holstein strains under two feeding strategies with different levels of pasture inclusion. PLOS ONE 2023; 18(10) doi: 10.1371/journal.pone.0290551
139
Avraham Mayevsky, Efrat Barbiro-Michaely. Use of NADH fluorescence to determine mitochondrial function in vivo. The International Journal of Biochemistry & Cell Biology 2009; 41(10) doi: 10.1016/j.biocel.2009.03.012
140
Elizabeth Hijona, Lander Hijona, Juan I. Arenas, Luis Bujanda. Inflammatory Mediators of Hepatic Steatosis. Mediators of Inflammation 2010; 2010 doi: 10.1155/2010/837419
141
Sakthi Priya Selvamani, Anis Khan, Enoch S E Tay, Matthew Garvey, Harout Ajoyan, Eve Diefenbach, Brian S Gloss, Thomas Tu, Jacob George, Mark W Douglas. Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis. The Journal of Infectious Diseases 2024; 230(5) doi: 10.1093/infdis/jiae210
142
Silvia Belia, Eleonora Urbani, Stefano Perni, Valeria Marsili, Graziana Lupattelli, Gaetano Vaudo, Anna Rita Roscini. Oxidative Balance in Lymphocytes From Patients With Nonalcoholic Steatohepatitis. The American Journal of the Medical Sciences 2014; 348(1) doi: 10.1097/MAJ.0000000000000191
143
Niveda Sundararaman, James Go, Aaron E. Robinson, José M. Mato, Shelly C. Lu, Jennifer E. Van Eyk, Vidya Venkatraman. PINE: An Automation Tool to Extract and Visualize Protein-Centric Functional Networks. Journal of the American Society for Mass Spectrometry 2020; 31(7) doi: 10.1021/jasms.0c00032
144
Catherine E. Aiken. Metabolic Syndrome. 2015;  doi: 10.1007/978-3-319-12125-3_14-1
145
Samaneh Shahsavani, Mohammad Fararouei, Mahmood Soveid, Mansooreh Dehghani, Mohammad Hoseini. Exposure to polycyclic aromatic hydrocarbon-induced oxidative stress in Shiraz, Iran: urinary levels, health risk assessment and mediation effect of MDA on the risk of metabolic syndromes. International Archives of Occupational and Environmental Health 2022; 95(5) doi: 10.1007/s00420-021-01822-8
146
Xianling Dai, Qin Kuang, Yan Sun, Minxuan Xu, Liancai Zhu, Chenxu Ge, Jun Tan, Bochu Wang. Fisetin represses oxidative stress and mitochondrial dysfunction in NAFLD through suppressing GRP78-mediated endoplasmic reticulum (ER) stress. Journal of Functional Foods 2022; 90 doi: 10.1016/j.jff.2022.104954
147
Norbert Stefan, Konstantinos Kantartzis, Hans-Ulrich Häring. Causes and Metabolic Consequences of Fatty Liver. Endocrine Reviews 2008; 29(7) doi: 10.1210/er.2008-0009
148
Kun Li, Bao Zhao, Diandian Wei, Wenrui Wang, Yixuan Cui, Lisheng Qian, Guodong Liu. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1. International Journal of Molecular Medicine 2019;  doi: 10.3892/ijmm.2019.4443
149
. Advances in Clinical Chemistry 2013; 59 doi: 10.1016/B978-0-12-405211-6.00006-1
150
Taylor J. Kelty, Alexa A. Krause, R. Scott Rector. Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies. American Journal of Physiology-Endocrinology and Metabolism 2025; 329(2) doi: 10.1152/ajpendo.00178.2025
151
M Banasch, J Frank, K Serova, K Knyhala, S Kollar, A Potthoff, NH Brockmeyer, O Goetze. Impact of antiretroviral treatment on 13C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Medicine 2011; 12(1) doi: 10.1111/j.1468-1293.2010.00847.x
152
Jorge Beleza, David Rizo-Roca, António Ascensão, José Magalhães. Mitochondrial Biology and Experimental Therapeutics. 2018;  doi: 10.1007/978-3-319-73344-9_18
153
M. M. Kondro, B. M. Verveha, T. V. Beregova, M. Y. Spivak, B. V. Gutyj. Lipid and phospholipid composition of the inner mitochondrial membrane of hepatocytes under conditions of glutamate-induced steatohepatosis and correction with nanocrystalline cerium dioxide. Regulatory Mechanisms in Biosystems 2025; 16(3) doi: 10.15421/0225137
154
Giulia Mollica, Pamela Senesi, Roberto Codella, Fernanda Vacante, Anna Montesano, Livio Luzi, Ileana Terruzzi. L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet. Digestive and Liver Disease 2020; 52(3) doi: 10.1016/j.dld.2019.09.002
155
Anne Negre-Salvayre, Nathalie Auge, Victoria Ayala, Huveyda Basaga, Jordi Boada, Rainer Brenke, Sarah Chapple, Guy Cohen, Janos Feher, Tilman Grune, Gabriella Lengyel, Giovanni E. Mann, Reinald Pamplona, Giuseppe Poli, Manuel Portero-Otin, Yael Riahi, Robert Salvayre, Shlomo Sasson, Jose Serrano, Ofer Shamni, Werner Siems, Richard C. M. Siow, Ingrid Wiswedel, Kamelija Zarkovic, Neven Zarkovic. Pathological aspects of lipid peroxidation. Free Radical Research 2010; 44(10) doi: 10.3109/10715762.2010.498478
156
Daniel M. Spielman, Dirk Mayer, Yi‐Fen Yen, James Tropp, Ralph E. Hurd, Adolf Pfefferbaum. In vivo measurement of ethanol metabolism in the rat liver using magnetic resonance spectroscopy of hyperpolarized [1‐13C]pyruvate. Magnetic Resonance in Medicine 2009; 62(2) doi: 10.1002/mrm.21998
157
Angel Carazo, Josefa León, Jorge Casado, Ana Gila, Sergio Delgado, Ana Martín, Laura Sanjuan, Trinidad Caballero, Jose Antonio Muñoz, Rosa Quiles, Angeles Ruiz-Extremera, Luis Miguel Alcázar, Javier Salmerón. Hepatic Expression of Adiponectin Receptors Increases with Non-alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1. Obesity Surgery 2011; 21(4) doi: 10.1007/s11695-010-0353-2
158
Antonella Amato, Gaetano-Felice Caldara, Domenico Nuzzo, Sara Baldassano, Pasquale Picone, Manfredi Rizzo, Flavia Mulè, Marta Di Carlo. NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. Nutrients 2017; 9(5) doi: 10.3390/nu9050492
159
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver disease. Molecular Aspects of Medicine 2017; 54 doi: 10.1016/j.mam.2016.11.008
160
William B. Ashworth, Nathan A. Davies, I. David L. Bogle, Daniel A Beard. A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD. PLOS Computational Biology 2016; 12(9) doi: 10.1371/journal.pcbi.1005105
161
Chander K. Negi, Sabbir Khan, Hubert Dirven, Lola Bajard, Luděk Bláha. Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084282
162
Alexandra Rankovic, Shoshana Verton-Shaw, Anna K. Shoveller, Marica Bakovic, Gordon Kirby, Adronie Verbrugghe. Dietary choline, but not L-carnitine, increases circulating lipid and lipoprotein concentrations, without affecting body composition, energy expenditure or respiratory quotient in lean and obese male cats during weight maintenance. Frontiers in Veterinary Science 2023; 10 doi: 10.3389/fvets.2023.1198175
163
Valerio Nobili, Anna Alisi, Melania Manco. Global Perspectives on Childhood Obesity. 2011;  doi: 10.1016/B978-0-12-374995-6.10021-0
164
Alyson Kaplan, Jennifer C. Price. HIV-Associated NAFLD: Disease Burden and Management. Current Hepatology Reports 2019; 18(4) doi: 10.1007/s11901-019-00501-0
165
Hannah Maude, Claudia Sanchez-Cabanillas, Inês Cebola. Epigenetics of Hepatic Insulin Resistance. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.681356
166
Pallavi Shukla, Srabani Mukherjee. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome. Mitochondrion 2020; 52 doi: 10.1016/j.mito.2020.02.006
167
Ahmad Hazim, Dyah Purnamasari, Kemal F. Kalista, C. Rinaldi A. Lesmana, Pringgodigdo Nugroho. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2) doi: 10.1016/j.dsx.2019.01.058
168
Metabolic Syndrome and Cardiovascular Disease. 2012;  doi: 10.1002/9781118480045.ch2
169
O. ULIČNÁ, O. VANČOVÁ, I. WACZULÍKOVÁ, P. BOŽEK, L. ŠIKUROVÁ, V. BADA, J. KUCHARSKÁ. Liver Mitochondrial Respiratory Function and Coenzyme Q Content in Rats on a Hypercholesterolemic Diet Treated With Atorvastatin. Physiological Research 2012;  doi: 10.33549/physiolres.932236
170
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Tobias Suske, Olaf Merkel, Lukas Kenner, Andreia Luís, Andrey Kozlov, Johannes Haybaeck, Mathias Müller, Xiaonan Han, Richard Moriggl. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine 2019; 124 doi: 10.1016/j.cyto.2018.10.010
171
Huifang Kang, Zhiwang Zhang, Lin Yu, Yixing Li, Mingzhen Liang, Lei Zhou. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation. Journal of Cellular Biochemistry 2018; 119(7) doi: 10.1002/jcb.26746
172
Lauren P. Westhaver, Sarah Nersesian, Riley J. Arseneau, Joshua Hefler, Breanna K.V. Hargreaves, Alexander Edgar, Yara Azizieh, Nerea Cuesta-Gomez, Dayne L. Izquierdo, A.M. James Shapiro, Boris L. Gala-Lopez, Jeanette E. Boudreau. Mitochondrial DNA levels in perfusate and bile during ex vivo normothermic machine correspond with donor liver quality. Heliyon 2024; 10(5) doi: 10.1016/j.heliyon.2024.e27122
173
Yida Zhang, Susan S. Baker, Robert D. Baker, Ruixin Zhu, Lixin Zhu, Anna Alisi. Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism. PLoS ONE 2012; 7(12) doi: 10.1371/journal.pone.0051131
174
Alessandra Ferramosca, Mariangela Di Giacomo, Vincenzo Zara. Antioxidant dietary approach in treatment of fatty liver: New insights and updates. World Journal of Gastroenterology 2017; 23(23): 4146-4157 doi: 10.3748/wjg.v23.i23.4146
175
A. A. Komar, D. A. Shunkina (Skuratovsvkaia), M. A. Vulf, H. Q. Vu, N. M. Todosenko, P. A. Zatolokin, E. V. Kirienkova, N. D. Gazatova, L. S. Litvinova. HEPATIC SOD1 GENE EXPRESSION CHANGES IN THE NAFLD PATHOGENESIS IN OBESITY. Medical Immunology (Russia) 2021; 23(4) doi: 10.15789/1563-0625-HSG-2282
176
Svetlana Rodimova, Artem Mozherov, Vadim Elagin, Maria Karabut, Ilya Shchechkin, Dmitry Kozlov, Dmitry Krylov, Alena Gavrina, Nikolai Bobrov, Vladimir Zagainov, Elena Zagaynova, Daria Kuznetsova. Effect of Hepatic Pathology on Liver Regeneration: The Main Metabolic Mechanisms Causing Impaired Hepatic Regeneration. International Journal of Molecular Sciences 2023; 24(11) doi: 10.3390/ijms24119112
177
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(2) doi: 10.3390/jcm9020314
178
Yongxin Liu, Yongqing Wei, Xiaolong Jin, Hongyu Cai, Qianqian Chen, Xiujuan Zhang. PDZD8 Augments Endoplasmic Reticulum-Mitochondria Contact and Regulates Ca2+ Dynamics and Cypd Expression to Induce Pancreatic β-Cell Death during Diabetes. Diabetes & Metabolism Journal 2024; 48(6) doi: 10.4093/dmj.2023.0275
179
Yumi Lee, Donghee Choi, Junghye Park, Jae Gwan Kim, Taejin Choi, Daehwan Youn. The Effects of Warm Acupuncture on the Expression of AMPK in High-Fat Diet-Induced MAFLD Rats. Current Issues in Molecular Biology 2024; 46(10) doi: 10.3390/cimb46100687
180
JONG-JEN KUO, HEN-HONG CHANG, TUNG-HU TSAI, TZUNG-YAN LEE. Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. International Journal of Molecular Medicine 2012; 30(3) doi: 10.3892/ijmm.2012.1020
181
Flora Guerra, Francesca Romana Ponziani, Ferdinando Cardone, Cecilia Bucci, Emanuele Marzetti, Anna Picca. Mitochondria-Derived Vesicles, Sterile Inflammation, and Pyroptosis in Liver Cancer: Partners in Crime or Innocent Bystanders?. International Journal of Molecular Sciences 2024; 25(9) doi: 10.3390/ijms25094783
182
Anthony O. Boateng, Vinood B. Patel, S. W. Annie Bligh. The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Biomolecules 2025; 15(5) doi: 10.3390/biom15050726
183
Romina M. Rodríguez, Antonio J. Cortés-Espinar, Jorge R. Soliz-Rueda, Christine Feillet-Coudray, François Casas, Marina Colom-Pellicer, Gerard Aragonès, Javier Avila-Román, Begoña Muguerza, Miquel Mulero, Maria Josepa Salvadó. Time-of-Day Circadian Modulation of Grape-Seed Procyanidin Extract (GSPE) in Hepatic Mitochondrial Dynamics in Cafeteria-Diet-Induced Obese Rats. Nutrients 2022; 14(4) doi: 10.3390/nu14040774
184
Weidong Bai, Bingqi Huang, Wenhong Zhao, Gongliang Liu, Limei Yu, Zhi Lu, Hong Wang. Management and Modification of Flavonoids Against Nonalcoholic Fatty Liver Disease. Food Bioengineering 2025; 4(3) doi: 10.1002/fbe2.70026
185
Norihiro Kubota, Shoichi Kado, Mitsuyoshi Kano, Norie Masuoka, Yuriko Nagata, Toshihide Kobayashi, Kouji Miyazaki, Fumiyasu Ishikawa. A high‐fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non‐alcoholic steatohepatitis in mice. Clinical and Experimental Pharmacology and Physiology 2013; 40(7) doi: 10.1111/1440-1681.12102
186
Ma Antonia Jiménez-Santos, Isela E Juárez-Rojop, Carlos A Tovilla-Zárate, María Teresa Espinosa-García, Marco A Juárez-Oropeza, Teresa Ramón-Frías, Deysi Y Bermúdez-Ocaña, Juan C Díaz-Zagoya. Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-22
187
Suzanne M. de la Monte, Ming Tong. Brain metabolic dysfunction at the core of Alzheimer's disease. Biochemical Pharmacology 2014; 88(4) doi: 10.1016/j.bcp.2013.12.012
188
Hezhongrong Nie, Xiaohong Yu, Haihong He, Lintao Zhou, Qing Li, Chunli Song, Damin Wang, Tingyu Ren, Zeyan Chen, Hanlian Huang, Xiaoyan Dai, Yiwen Zhou. Hepatocyte miR‐33a mediates mitochondrial dysfunction and hepatosteatosis by suppressing NDUFA5. Journal of Cellular and Molecular Medicine 2018; 22(12) doi: 10.1111/jcmm.13918
189
Alexandra Feldman, Elmar Aigner, Daniel Weghuber, Katharina Paulmichl. The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. BioMed Research International 2015; 2015 doi: 10.1155/2015/287401
190
Keum Bit Hwang, Yi Yi Kyaw, Hyo Rin Kang, Mi So Seong, JaeHun Cheong. Mitochondrial dysfunction stimulates HBV gene expression through lipogenic transcription factor activation. Virus Research 2020; 277 doi: 10.1016/j.virusres.2019.197842
191
Carine Lindquist, Bodil Bjørndal, Christine Renate Rossmann, Deusdedit Tusubira, Asbjørn Svardal, Gro Vatne Røsland, Karl Johan Tronstad, Seth Hallström, Rolf Kristian Berge. Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats. Journal of Lipid Research 2017; 58(7) doi: 10.1194/jlr.M074849
192
Catherine E. Aiken. Metabolic Syndrome. 2016;  doi: 10.1007/978-3-319-11251-0_14
193
Hai-Yan Ni, Liang Yu, Xue-Lian Zhao, Li–Tao Wang, Chun–Jian Zhao, Han Huang, Han-Lin Zhu, Thomas Efferth, Cheng-Bo Gu, Yu-Jie Fu. Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism. Phytomedicine 2022; 98 doi: 10.1016/j.phymed.2021.153919
194
Benjamin L. Farah, Rohit A. Sinha, Yajun Wu, Brijesh K. Singh, Andrea Lim, Masahiro Hirayama, Dustin J. Landau, Boon Huat Bay, Dwight D. Koeberl, Paul M. Yen. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa). Scientific Reports 2017; 7(1) doi: 10.1038/srep44408
195
Jiali Wu, Su Lin, Bo Wan, Bharat Velani, Yueyong Zhu. Pyroptosis in Liver Disease: New Insights into Disease Mechanisms. Aging and disease 2019; 10(5) doi: 10.14336/AD.2019.0116
196
Thekkuttuparambil Ananthanarayanan Ajith. Role of mitochondria and mitochondria‐targeted agents in non‐alcoholic fatty liver disease. Clinical and Experimental Pharmacology and Physiology 2018; 45(5) doi: 10.1111/1440-1681.12886
197
Angeliki Papachristodoulou, Dimitrios Kavvadas, Athanasios Karamitsos, Theodora Papamitsou, Maria Chatzidimitriou, Antonia Sioga. Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?. Pediatric Reports 2021; 13(2) doi: 10.3390/pediatric13020039
198
James W. Perfield, Laura C. Ortinau, R. Taylor Pickering, Meghan L. Ruebel, Grace M. Meers, R. Scott Rector. Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice. Journal of Obesity 2013; 2013 doi: 10.1155/2013/296537
199
Xing-Xin Yang, Xi Wang, Ting-Ting Shi, Jin-Cai Dong, Feng-Jiao Li, Lin-Xi Zeng, Min Yang, Wen Gu, Jing-Ping Li, Jie Yu. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum. Biomedicine & Pharmacotherapy 2019; 117 doi: 10.1016/j.biopha.2019.109083
200
Wei Xuan, Dandan Song, Youyou Yan, Ming Yang, Yan Sun, Nicoletta Guaragnella. A Potential Role for Mitochondrial DNA in the Activation of Oxidative Stress and Inflammation in Liver Disease. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/5835910
201
Timea Csak, Angela Dolganiuc, Karen Kodys, Bharath Nath, Jan Petrasek, Shashi Bala, Dora Lippai, Gyongyi Szabo. Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice. Hepatology 2011; 53(6) doi: 10.1002/hep.24301
202
Rory P. Cunningham, Ryan D. Sheldon, R. Scott Rector. The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00767
203
Devon S. Svoboda, Michael D. Kawaja. Changes in hepatic protein expression in spontaneously hypertensive rats suggest early stages of non-alcoholic fatty liver disease. Journal of Proteomics 2012; 75(6) doi: 10.1016/j.jprot.2011.12.011
204
Kiseok Kim, Yong-Jin Lee, Soon-Chan Kwon, Young-Sun Min, Hyun Kyo Lee, Gwangin Baek, Sang Hyeon Kim, Eun-Chul Jang. Correlation between shift work and non-alcoholic fatty liver disease among male workers in the steel manufacturing company of Korea: a cross-sectional study. Annals of Occupational and Environmental Medicine 2022; 34(1) doi: 10.35371/aoem.2022.34.e33
205
Robert Hirten, Henry C. Bodenheimer, David Bernstein. Principles of Diabetes Mellitus. 2015;  doi: 10.1007/978-3-319-20797-1_35-1
206
Andrea Eynaudi, Francisco Díaz-Castro, Juan Carlos Bórquez, Roberto Bravo-Sagua, Valentina Parra, Rodrigo Troncoso. Differential Effects of Oleic and Palmitic Acids on Lipid Droplet-Mitochondria Interaction in the Hepatic Cell Line HepG2. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.775382
207
Giuseppe Paradies, Valeria Paradies, Francesca M Ruggiero, Giuseppe Petrosillo. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(39): 14205-14218 doi: 10.3748/wjg.v20.i39.14205
208
Oliver Glass, Daniel Liu, Elizabeth Bechard, Cynthia D. Guy, Jane Pendergast, Anna Mae Diehl, Manal F. Abdelmalek. Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study. Hepatology Communications 2022; 6(2) doi: 10.1002/hep4.1808
209
Mingyan Zhou, Catherine Li, Frances L. Byrne, Calum S. Vancuylenburg, Ellen M. Olzomer, Adam Hargreaves, Lindsay E. Wu, Nicholas A. Shackel, Webster L. Santos, Kyle L. Hoehn. Beneficial effects of MGL‐3196 and BAM15 combination in a mouse model of fatty liver disease. Acta Physiologica 2024; 240(10) doi: 10.1111/apha.14217
210
I.O. Gonçalves, M.J. Martins, J. Beleza, A. Ascensão, J. Magalhães. Liver Pathophysiology. 2017;  doi: 10.1016/B978-0-12-804274-8.00024-2
211
Zohreh Sadat Sangsefidi, Mahdieh Hosseinzadeh, Ali Mohammad Ranjbar, Mohsen Akhondi-Meybodi, Hossein Fallahzadeh, Hassan Mozaffari-Khosravi. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial. Nutrition Journal 2019; 18(1) doi: 10.1186/s12937-019-0465-z
212
Nora V. Bergasa. Clinical Cases in Hepatology. 2022;  doi: 10.1007/978-1-4471-4715-2_9
213
David G. Cotter, Baris Ercal, Xiaojing Huang, Jamison M. Leid, D. André d’Avignon, Mark J. Graham, Dennis J. Dietzen, Elizabeth M. Brunt, Gary J. Patti, Peter A. Crawford. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. Journal of Clinical Investigation 2014; 124(12) doi: 10.1172/JCI76388
214
Otto Kučera, René Endlicher, Tomáš Roušar, Halka Lotková, Tomáš Garnol, Zdeněk Drahota, Zuzana Červinková. The Effect oftert-Butyl Hydroperoxide-Induced Oxidative Stress on Lean and Steatotic Rat HepatocytesIn Vitro. Oxidative Medicine and Cellular Longevity 2014; 2014 doi: 10.1155/2014/752506
215
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094807
216
Jelena Stevanović, Jorge Beleza, Pedro Coxito, António Ascensão, José Magalhães. Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. Molecular Metabolism 2020; 32 doi: 10.1016/j.molmet.2019.11.015
217
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho, Yuan Xu. Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/4956079
218
RORY P. CUNNINGHAM, MARY P. MOORE, GRACE M. MEERS, GREGORY N. RUEGSEGGER, FRANK W. BOOTH, R. SCOTT RECTOR. Maternal Physical Activity and Sex Impact Markers of Hepatic Mitochondrial Health. Medicine & Science in Sports & Exercise 2018; 50(10) doi: 10.1249/MSS.0000000000001675
219
Maciej Suski, Rafał Olszanecki, Józef Madej, Justyna Totoń-Żurańska, Anna Niepsuj, Jacek Jawień, Beata Bujak-Giżycka, Krzysztof Okoń, Ryszard Korbut. Proteomic analysis of changes in protein expression in liver mitochondria in apoE knockout mice. Journal of Proteomics 2011; 74(6) doi: 10.1016/j.jprot.2011.03.003
220
Wylly Ramsés García-Niño, Edilia Tapia, Cecilia Zazueta, Zyanya Lucía Zatarain-Barrón, Rogelio Hernández-Pando, Claudia Cecilia Vega-García, José Pedraza-Chaverrí. Curcumin Pretreatment Prevents Potassium Dichromate-Induced Hepatotoxicity, Oxidative Stress, Decreased Respiratory Complex I Activity, and Membrane Permeability Transition Pore Opening. Evidence-Based Complementary and Alternative Medicine 2013; 2013 doi: 10.1155/2013/424692
221
Veena Gopinath, Vaishak Penarveettil Nair, Achuthan C. Raghavamenon. Fatty Liver Promotes Stress-resistant Mitochondria-mediated Hepatic Cellular Proliferation: Implication for the Development of Hepatocellular Carcinoma. Journal of Advanced Health Research & Clinical Medicine 2025; 2(2) doi: 10.4103/JHCR.JHCR_19_25
222
Nicholas R. L. Lind, Qingwen Qian, Ling Yang. ER Stress and Autophagy in Obesity and Nonalcoholic Fatty Liver Disease. Current Pathobiology Reports 2017; 5(3) doi: 10.1007/s40139-017-0145-7
223
Areum Daseul Kim, Kyoung Ah Kang, Mei Jing Piao, Ki Cheon Kim, Jian Zheng, Cheng Wen Yao, Ji Won Cha, Chang Lim Hyun, Hee Kyoung Kang, Nam Ho Lee, Jin Won Hyun. Cytoprotective Effect of Eckol Against Oxidative Stress‐Induced Mitochondrial Dysfunction: Involvement of the FoxO3a/AMPK Pathway. Journal of Cellular Biochemistry 2014; 115(8) doi: 10.1002/jcb.24790
224
Naomi Lomeli, Daniela A. Bota, Kelvin J.A. Davies. Diminished stress resistance and defective adaptive homeostasis in age-related diseases. Clinical Science 2017; 131(21) doi: 10.1042/CS20160982
225
Elda Cristina Villaseñor-Tapia, Edgar Rubén Mendieta-Condado, David Alejandro Curiel-Pedraza, Edwin Estefan Reza-Zaldívar, Ana Laura Márquez-Aguirre, Venkata Ramireddy Narala. Mitochondrial Dysfunction in MASLD: Evidence in Dietary Models and Potential Therapeutic Interventions. Biochemistry Research International 2026; 2026(1) doi: 10.1155/bri/6641383
226
Young-Mi Go, Roy L. Sutliff, Joshua D. Chandler, Rahman Khalidur, Bum-Yong Kang, Frank A. Anania, Michael Orr, Li Hao, Bruce A. Fowler, Dean P. Jones. Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice. Toxicological Sciences 2015; 147(2) doi: 10.1093/toxsci/kfv149
227
Paola Dongiovanni, Anna Ludovica Fracanzani, Silvia Fargion, Luca Valenti. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. Journal of Hepatology 2011; 55(4) doi: 10.1016/j.jhep.2011.05.008
228
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni, Mohammad-Javad Hosseinzadeh-Attar. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. BMJ Open 2017; 7(7) doi: 10.1136/bmjopen-2017-016914
229
Mireia López-Riera, Isabel Conde, Laia Tolosa, Ángela Zaragoza, José V. Castell, María J. Gómez-Lechón, Ramiro Jover. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00003
230
Mona Synnøve Bjune, Carine Lindquist, Marit Hallvardsdotter Stafsnes, Bodil Bjørndal, Per Bruheim, Thomas A. Aloysius, Ottar Nygård, Jon Skorve, Lise Madsen, Simon N. Dankel, Rolf Kristian Berge. Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(4) doi: 10.1016/j.bbalip.2021.158887
231
J. Schleicher, R. Guthke, U. Dahmen, O. Dirsch, H.G. Holzhuetter, S. Schuster. A theoretical study of lipid accumulation in the liver—implications for nonalcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014; 1841(1) doi: 10.1016/j.bbalip.2013.08.016
232
Grace E. Shryack, Alexa A. Krause, Simone Hernandez Ruano, Laura C. Schulz, Kathleen A. Pennington, R. Scott Rector. A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1498764
233
Pranay Wal, Shweta Yadav, Sajal Kumar Jha, Akanksha Singh, B. Bhargavi, Rekha Shivaram, Mohd Imran, Namra Aziz. Role of natural compounds in non-alcoholic fatty liver diseases (NAFLD): a mechanistic approach. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00452-w
234
Sien Lai, Dongsheng Tang, Juan Feng. Mitochondrial targeted therapies in MAFLD. Biochemical and Biophysical Research Communications 2025; 753 doi: 10.1016/j.bbrc.2025.151498
235
Viktoriia Starokozhko, Getahun B. Abza, Hedy C. Maessen, Marjolijn T. Merema, Frieke Kuper, Geny M.M. Groothuis. Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium. Toxicology in Vitro 2015; 30(1) doi: 10.1016/j.tiv.2015.10.008
236
Fernando Bessone, Melisa Dirchwolf, María Agustina Rodil, María Valeria Razori, Marcelo G. Roma. Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view. Alimentary Pharmacology & Therapeutics 2018; 48(9) doi: 10.1111/apt.14952
237
Georgios Kalopitas, Konstantinos Arvanitakis, Olga Tsachouridou, Konstantinos Malandris, Theocharis Koufakis, Symeon Metallidis, Georgios Germanidis. Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection. Life 2024; 14(6) doi: 10.3390/life14060742
238
Zengpeng Lv, Kun Xing, Guang Li, Dan Liu, Yuming Guo. Dietary Genistein Alleviates Lipid Metabolism Disorder and Inflammatory Response in Laying Hens With Fatty Liver Syndrome. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01493
239
Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends. A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?. Infectious Diseases and Therapy 2019; 8(1) doi: 10.1007/s40121-018-0229-7
240
Pablo Fernández-Tussy, Magdalena P. Cardelo, Hanming Zhang, Jonathan Sun, Nathan L. Price, Nabil E. Boutagy, Leigh Goedeke, Martí Cadena-Sandoval, Chrysovalantou E. Xirouchaki, Wendy Brown, Xiaoyong Yang, Oscar Pastor-Rojo, Rebecca A. Haeusler, Anton M. Bennett, Tony Tiganis, Yajaira Suárez, Carlos Fernández-Hernando. miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression. JCI Insight 2024; 9(19) doi: 10.1172/jci.insight.168476
241
Yanjuan Li, Pengquan Wang, Huan Yang, Jinbiao He, Yu Yang, Yuxuan Tao, Min Zhang, Mei Zhang, Jie Yu, Xingxin Yang. In vivo identification of bioactive components of Poria cocos for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease. Heliyon 2024; 10(16) doi: 10.1016/j.heliyon.2024.e35645
242
Aldo Ferreira-Hermosillo, Patricia V Torres-Duran, Marco A Juarez-Oropeza. Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series. Journal of Medical Case Reports 2010; 4(1) doi: 10.1186/1752-1947-4-103
243
Mohamad Khalil, Harshitha Shanmugam, Hala Abdallah, Jerlin Stephy John Britto, Ilaria Galerati, Javier Gómez-Ambrosi, Gema Frühbeck, Piero Portincasa. The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome. Nutrients 2022; 14(15) doi: 10.3390/nu14153112
244
Carolina M Pusec, Adam De Jesus, Md Wasim Khan, Alexander R Terry, Anton E Ludvik, Kai Xu, Nicholas Giancola, Haaris Pervaiz, Emily Daviau Smith, Xianzhong Ding, Stephen Harrison, Navdeep S Chandel, Thomas C Becker, Nissim Hay, Hossein Ardehali, Jose Cordoba-Chacon, Brian T Layden. Hepatic HKDC1 Expression Contributes to Liver Metabolism. Endocrinology 2019; 160(2) doi: 10.1210/en.2018-00887
245
Karen Lee Ann Chen, Yiru Chen Zhao, Kadriye Hieronymi, Brandi Patricia Smith, Zeynep Madak-Erdogan, Catherine Mounier. Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health. PLOS ONE 2017; 12(12) doi: 10.1371/journal.pone.0189911
246
Zachary J W Easton, Flavien Delhaes, Katherine Mathers, Lin Zhao, Christina M G Vanderboor, Timothy R H Regnault. Syncytialization and prolonged exposure to palmitate impacts BeWo respiration. Reproduction 2021; 161(1) doi: 10.1530/REP-19-0433
247
Wing Pak, Fusako Takayama, Manaka Mine, Kazuo Nakamoto, Yasumasa Kodo, Mitsumasa Mankura, Toru Egashira, Hiromu Kawasaki, Akitane Mori. Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis. Journal of Clinical Biochemistry and Nutrition 2012;  doi: 10.3164/jcbn.12-18
248
Nina L. Gluchowski, Michel Becuwe, Tobias C. Walther, Robert V. Farese. Lipid droplets and liver disease: from basic biology to clinical implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(6) doi: 10.1038/nrgastro.2017.32
249
Norshalizah Mamikutty, Zar Chi Thent, Farihah Haji Suhaimi. Fructose-Drinking Water Induced Nonalcoholic Fatty Liver Disease and Ultrastructural Alteration of Hepatocyte Mitochondria in Male Wistar Rat. BioMed Research International 2015; 2015 doi: 10.1155/2015/895961
250
A-Hyeon Lee, Ju Hee Oh, Hyun Sung Kim, Jeong-Hun Shin, Eileen L. Yoon, Dae Won Jun. Peripheral blood mononuclear cell mitochondrial copy number and adenosine triphosphate inhibition test in NAFLD. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.967848
251
Amreen Dinani, Ali Khan, Douglas Dieterich. Emerging Prevalence of Fatty Liver Disease in HIV. Future Virology 2021; 16(1) doi: 10.2217/fvl-2020-0184
252
Rory P. Cunningham, Mary P. Moore, Ryan J. Dashek, Grace M. Meers, Takamune Takahashi, Ryan D. Sheldon, Andrew A. Wheeler, Alberto Diaz-Arias, Jamal A. Ibdah, Elizabeth J. Parks, John P. Thyfault, R. Scott Rector. Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH. Diabetes 2021; 70(11) doi: 10.2337/db20-1228
253
Suzanne M. de la Monte, Ming Tong. Metabolic Syndrome and Neurological Disorders. 2013;  doi: 10.1002/9781118395318.ch1
254
Lei Zhou, Xiaolan Yu, Qingjie Meng, Hongqiang Li, Congcong Niu, Yun Jiang, Yuxi Cai, Minghui Li, Qiang Li, Chaoqiang An, Le Shu, Ao Chen, Handong Su, Yin Tang, Shen Yin, Silja Raschke, Kristin Eckardt, Jürgen Eckel, Zaiqing Yang. Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. Hepatology 2013; 57(4) doi: 10.1002/hep.26167
255
Qian Zhong, Yang Xiong, Yiwen Zhu, Qiuhong Ouyang, Xinglv Chen, Feng Qin, Fujian Xu, Kang An, Bingran Yu, Meng Qin. Nanomedicine targeting vascular endothelial dysfunction in metabolic diseases: Mechanisms and therapeutic opportunities. Journal of Controlled Release 2026; 395 doi: 10.1016/j.jconrel.2026.114940
256
Gaurab Bhaduri, Anchin Kalia, Banshi Saboo, Sanjay Bandyopadhyay. The Mitochondrial–Autophagy Axis in MASLD: Mechanisms, Crosstalk, and Therapeutic Targets. Comprehensive Physiology 2026; 16(3) doi: 10.1002/cph4.70155
257
Luis A. Videla, Andrea Marimán, Bastián Ramos, María José Silva, Andrea del Campo. Standpoints in mitochondrial dysfunction: Underlying mechanisms in search of therapeutic strategies. Mitochondrion 2022; 63 doi: 10.1016/j.mito.2021.12.006
258
Yanzou Dong, Kelong Sun, Han Chen, Yueyun Guo, Zishang Liu, Sisi Xiong, Wenbin Liu, Xiangfei Li. Dietary bile acids supplementation improves the growth performance, glycolipid metabolism and bile acids homeostasis of blunt snout bream (Megalobrama amblycephala) fed a high-carbohydrate diet. Aquaculture 2026; 620 doi: 10.1016/j.aquaculture.2026.743957
259
Luis A. Videla, Rodrigo Valenzuela. Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. BioFactors 2022; 48(2) doi: 10.1002/biof.1797
260
Laura Mairinoja, Hanna Heikelä, Sami Blom, Darshan Kumar, Anna Knuuttila, Sonja Boyd, Nelli Sjöblom, Eva-Maria Birkman, Petteri Rinne, Pekka Ruusuvuori, Leena Strauss, Matti Poutanen. Deep Learning–Based Image Analysis of Liver Steatosis in Mouse Models. The American Journal of Pathology 2023; 193(8) doi: 10.1016/j.ajpath.2023.04.014
261
Elango Kathirvel, Kengathevy Morgan, Samuel W. French, Timothy R. Morgan. Acetyl-l-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Nutrition Research 2013; 33(11) doi: 10.1016/j.nutres.2013.08.001
262
Chun-xue Li, Li-rong Shen. New observations on the effect of camellia oil on fatty liver disease in rats. Journal of Zhejiang University-SCIENCE B 2020; 21(8) doi: 10.1631/jzus.B2000101
263
Cuiping Shao, Youqing Xu. PI3K/AKT signaling pathway plays an important role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-07612-3
264
Mi-Bo Kim, Jaeeun Lee, Ji-Young Lee. Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components. Journal of Lipid and Atherosclerosis 2024; 13(3) doi: 10.12997/jla.2024.13.3.306
265
Jeong Su Park, Da Hyun Lee, Yu Seol Lee, Eunji Oh, Kwang-Hee Bae, Kyoung-Jin Oh, Hyunmi Kim, Soo Han Bae. Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity. Autophagy 2020; 16(1) doi: 10.1080/15548627.2019.1598751
266
Trenton Glaser, Leonardo Baiocchi, Tianhao Zhou, Heather Francis, Ilaria Lenci, Giuseppe Grassi, Lindsey Kennedy, Suthat Liangpunsakul, Shannon Glaser, Gianfranco Alpini, Fanyin Meng. Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. Journal of Cellular and Molecular Medicine 2020; 24(11) doi: 10.1111/jcmm.15182
267
Munirah Alsaleh, Paiboon Sithithaworn, Narong Khuntikeo, Watcharin Loilome, Puangrat Yongvanit, Thomas Hughes, Thomas O'Connor, Ross H. Andrews, Christopher A. Wadsworth, Roger Williams, Larry Koomson, Isobel Jane Cox, Elaine Holmes, Simon D. Taylor-Robinson. Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma—A Follow-Up Study. Journal of Clinical and Experimental Hepatology 2023; 13(2) doi: 10.1016/j.jceh.2022.11.012
268
Eva Gijbels, Mathieu Vinken. Experimental Cholestasis Research. Methods in Molecular Biology 2019; 1981 doi: 10.1007/978-1-4939-9420-5_1
269
Francisco-Javier García-Alonso, Verónica García-Valverde, Inmaculada Navarro-González, Gala Martín-Pozuelo, Rocío González-Barrio, María Jesús Periago. Nutritional Composition and Antioxidant Properties of Fruits and Vegetables. 2020;  doi: 10.1016/B978-0-12-812780-3.00015-5
270
Keisuke Yamamoto, Kazuna Takahara, Seiichi Oyadomari, Tetsuya Okada, Takashi Sato, Akihiro Harada, Kazutoshi Mori, Ramanujan S. Hegde. Induction of Liver Steatosis and Lipid Droplet Formation in ATF6α-Knockout Mice Burdened with Pharmacological Endoplasmic Reticulum Stress. Molecular Biology of the Cell 2010; 21(17) doi: 10.1091/mbc.e09-02-0133
271
Walid E. Zahran, Kholoud A. Salah El-Dien, Philip G. Kamel, Ahmed Shawky El-Sawaby. Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression. Indian Journal of Clinical Biochemistry 2013; 28(2) doi: 10.1007/s12291-012-0236-5
272
M Sahuri-Arisoylu, L P Brody, J R Parkinson, H Parkes, N Navaratnam, A D Miller, E L Thomas, G Frost, J D Bell. Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate. International Journal of Obesity 2016; 40(6) doi: 10.1038/ijo.2016.23
273
Yong Zhang, Longchang Jiang, Wenjun Hu, Qichang Zheng, Wenpei Xiang. Mitochondrial dysfunction during in vitro hepatocyte steatosis is reversed by omega-3 fatty acid–induced up-regulation of mitofusin 2. Metabolism 2011; 60(6) doi: 10.1016/j.metabol.2010.07.026
274
J. Rieusset. Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles?. Diabetes & Metabolism 2015; 41(5) doi: 10.1016/j.diabet.2015.02.006
275
Santhosh Satapati, Blanka Kucejova, Joao A.G. Duarte, Justin A. Fletcher, Lacy Reynolds, Nishanth E. Sunny, Tianteng He, L. Arya Nair, Kenneth Livingston, Xiaorong Fu, Matthew E. Merritt, A. Dean Sherry, Craig R. Malloy, John M. Shelton, Jennifer Lambert, Elizabeth J. Parks, Ian Corbin, Mark A. Magnuson, Jeffrey D. Browning, Shawn C. Burgess. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. Journal of Clinical Investigation 2015; 125(12) doi: 10.1172/JCI82204
276
Claudia Kemper, Michael N. Sack. Linking nutrient sensing, mitochondrial function, and PRR immune cell signaling in liver disease. Trends in Immunology 2022; 43(11) doi: 10.1016/j.it.2022.09.002
277
Inês O. Gonçalves, Paulo J. Oliveira, António Ascensão, José Magalhães. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. European Journal of Clinical Investigation 2013; 43(11) doi: 10.1111/eci.12146
278
Yong-Jik Lee, Yoo-Na Jang, Yoon-Mi Han, Hyun-Min Kim, Jong-Min Jeong, Hong Seog Seo. Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions. PPAR Research 2017; 2017 doi: 10.1155/2017/8048720
279
Fernando Moreto, Erick P. de Oliveira, Rodrigo M. Manda, Roberto C. Burini. The Higher Plasma Malondialdehyde Concentrations Are Determined by Metabolic Syndrome-Related Glucolipotoxicity. Oxidative Medicine and Cellular Longevity 2014; 2014 doi: 10.1155/2014/505368
280
Gala Martín-Pozuelo, Rocío González-Barrio, Gonzalo Barberá, Amaya Albalat, Javier García-Alonso, William Mullen, Harald Mischak, María Periago. Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis. International Journal of Molecular Sciences 2016; 17(11) doi: 10.3390/ijms17111789
281
Naho Kitamura, Yoko Yokoyama, Hiroki Taoka, Utana Nagano, Shotaro Hosoda, Tanon Taworntawat, Anna Nakamura, Yoko Ogawa, Kazuo Tsubota, Mitsuhiro Watanabe. Iron supplementation regulates the progression of high fat diet induced obesity and hepatic steatosis via mitochondrial signaling pathways. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89673-8
282
Chelsea N. Johnson, Reilly S. Jensen, Alex T. Von Schulze, Paige C. Geiger. Heat Therapy Can Improve Hepatic Mitochondrial Function and Glucose Control. Exercise and Sport Sciences Reviews 2022; 50(3) doi: 10.1249/JES.0000000000000296
283
Kazuo Nakamoto, Fusako Takayama, Mitsumasa Mankura, Yuki Hidaka, Toru Egashira, Tetsuya Ogino, Hiromu Kawasaki, Akitane Mori. Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis. Journal of Clinical Biochemistry and Nutrition 2009; 44(3) doi: 10.3164/jcbn.08-256
284
Elmar Aigner, Michael Strasser, Heike Haufe, Thomas Sonnweber, Florian Hohla, Andreas Stadlmayr, Marc Solioz, Herbert Tilg, Wolfgang Patsch, Guenter Weiss, Felix Stickel, Christian Datz. A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology 2010; 105(9) doi: 10.1038/ajg.2010.170
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.